A Cross-Sectional Survey Study of Cannabis Use for Fibromyalgia Symptom Management.
Autor: | Singla A; Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA. Electronic address: singla.abhinav@mayo.edu., Anstine CV; Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA., Huang L; Pharmacy Services, Mayo Clinic, Rochester, MN, USA., Rosedahl JK; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Mohabbat AB; Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA., Philpot LM; Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Mayo Clinic proceedings [Mayo Clin Proc] 2024 Apr; Vol. 99 (4), pp. 542-550. |
DOI: | 10.1016/j.mayocp.2023.12.018 |
Abstrakt: | Objective: To assess the use of cannabis as a symptom management strategy for patients with fibromyalgia. Patients and Methods: An electronic, cross-sectional survey was conducted among patients diagnosed with fibromyalgia and treated in Integrative Medicine & Health at Mayo Clinic, Rochester, Minnesota. The survey was constructed with the Symptom Management Theory tool and was sent anonymously via web-based software to patients with a diagnosis of fibromyalgia. Results: Of 5234 patients with fibromyalgia sent the online survey, 1336 (25.5%) responded and met the inclusion criteria. Survey respondents had a median age of 48 (Q1-Q3: 37.5-58.0) years, and most identified as female. Nearly half of respondents (49.5%, n=661) reported cannabis use since their fibromyalgia diagnosis. The most common symptoms for which respondents reported using cannabis were pain (98.9%, n=654); fatigue (96.2%; n=636); stress, anxiety, or depression (93.9%; n=621); and insomnia (93.6%; n=619). Improvement in pain symptoms with cannabis use was reported by 82.0% (n=536). Most cannabis-using respondents reported that cannabis also improved symptoms of stress, anxiety, and depression and of insomnia. Conclusion: Considering that cannabis is a popular choice among patients for managing fibromyalgia symptoms, clinicians should have adequate knowledge of cannabis when discussing therapeutic options for fibromyalgia with their patients. (Copyright © 2024 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |